Inactive
Notice ID:HHSNgLYCEROL05052021
DESCRIPTION: The National Institutes of Health - NICHD intends to procure the services of a contractor to provide (chemical reagent) Glycerol-2-13C, 99 ATOM % 13C needed for analysis of hepatic glucon...
DESCRIPTION: The National Institutes of Health - NICHD intends to procure the services of a contractor to provide (chemical reagent) Glycerol-2-13C, 99 ATOM % 13C needed for analysis of hepatic gluconeogenesis in Colchicine clinical protocol supported by this Bench to Bedside application. The chemicals are needed for an ongoing project. This is a combined synopsis/ solicitation for commercial items prepared in accordance with the format in FAR 12.6 and FAR 13 as supplemented with additional information included in this notice # NICHDClycerol05052021. In order to comply with the requirements in this notice, the responses should be based on our interpretation of the general requirements provided below. This announcement constitutes the only solicitation as the program already issued a separate solicitation and received some quotes which will be evaluated at the same time as any other quotes/proposals received after this notice is completed. In order to be considered for award the offeror must provide all required supplies to the exact specification – below: GLYCEROL : (13C3, 99%) MICROBIOLOGICAL/PYROGEN TESTED PACKAGED AS 135 X 1G IN 4ML SCREWCAP BOTTLES PLUS 54 X 2.5G IN 4ML SCREWCAP BOTTLES PACKAGED IN LAMINAR FLOW HOOD Should there be a special charge for packaging, the fee should be added as a separate line item on your quote. Basic Description: Synonym(s): 1,2,3-Propanetriol-C; C Labeled glycerol; Glycerin-C Empirical Formula: CHO Linear Formula: (HOCH)CHOH Formula Weight: 95.07 MDL Number: MFCD00083975 Boiling Point: 182 °C(lit.) Melting Point: 20 °C(lit.) Density: 1.302 g/mL at 25 °C Refractive Index: n20/D 1.474(lit.) FOR ALL MICROBIOLOGICAL & PYROGEN TESTED MATERIA THE BULK LOT IS TESTED AT RELEASE FOR: S.aureus, P.aeruginosa, E. coli, Salmonella sp., AEROBIC BACTERIA, YEAST, MOLD, BACTERIAL ENDOTOXI AND HEAVY METALS. NOTE THAT CIL PERFORMS RELEASE TESTING ONLY ON THE BULK LOT. SUBSEQUENT ALIQUOT Product Service Code: 6505 - DRUGS AND BIOLOGICALS NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing This synopsis is a request for competitive quotes and/or proposals. Interested persons may identify their interest and capability to respond to the requirement or submit quotations. All quotes received within the time and date of publication of this notice will be considered by the Government. HOW TO RESPOND: In order to compete for this project, interested parties must be registered in the Central Contracting Registration, aka SAM.Gov and submit a price quotation by 9:00 am, ET, May 20th 2021. Offerors may either submit one copy of the quote to MOE FILALI by mail or preferably via email. Electronic transmissions to Moe.Filali@nih.gov are preferable but must be timely. It is the responsibility of the Offeror to ensure the proposal is received by the date and time shown above. The following Federal Acquisition Regulations clauses are incorporated by reference: FAR 52.212-3, Offeror Representations and Certifications-Commercial Items (Mar 2005), 52.212-4 (Sept 2005), 52.212-5, Contract Terms and Conditions Required to Implement Statutes of Executive Orders-Commercial Items (Aug 2006). (6)(i) 52.222-26, Equal Opportunity (Apr 2002) (E.O. 11246). (18) 52.222-35, Equal Opportunity for Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans (Dec 2001) (38 U.S.C. 4212). (19) 52.222-36, Affirmative Action for Workers with Disabilities (Jun 1998) (29 U.S.C. 793). (20) 52.222-37, Employment Reports on Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans (Dec 2001) (38 U.S.C. 4212). (31) 52.232-33, Payment by Electronic Funds Transfer-Central Contractor Registration (Oct 2003) (31 U.S.C. 3332). Other Clauses such as Section 889- FAR 52-212-24.25 will be considered at the time of award… Primary Point of Contact: MOE FILALI Contracting Office Address: NIH/NICHD Office of Acquisitions 6710B Rockledge Drive, Room 1145D Bethesda, MD 20817 (w) 301.827 7737 Moe.filali@nih.gov
